Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
BeOne Medicines
BeOne Medicines
(ONC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Brukinsa
Zanubrutinib
2019-11-14
2034-2043
Mantle-cell lymphoma
,
Waldenstrom macroglobulinemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Zanubrutinib
healthy volunteers/patients
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myelomonocytic leukemia chronic
,
t-cell lymphoma
,
myeloid leukemia
,
reactive arthritis
,
large b-cell lymphoma diffuse
,
recurrence
,
neoplasms
,
hematologic neoplasms
,
covid-19
,
monoclonal gammopathy of undetermined significance
,
b-cell chronic lymphocytic leukemia
,
mantle-cell lymphoma
,
lymphoma
,
b-cell lymphoma
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
lymphoid leukemia
,
leukemia
,
non-hodgkin lymphoma
,
membranous glomerulonephritis
,
waldenstrom macroglobulinemia
Docusate
healthy volunteers/patients
,
diarrhea
,
covid-19
Histidine
graves ophthalmopathy
Benzimidazole
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
,
psoriatic arthritis
,
psoriasis
,
alzheimer disease
,
liver failure
,
hepatic insufficiency
,
obesity
,
insulin resistance
,
overweight
,
acute coronary syndrome
,
cardiac catheterization
,
heart valve prosthesis
,
venous thrombosis
,
systolic murmurs
,
polycystic kidney diseases
,
chronic renal insufficiency
,
chronic kidney failure
,
secondary prevention
,
neoplasm metastasis
,
replacement arthroplasty knee
,
hematoma
,
dyslipidemias
,
disease progression
,
embolic stroke
,
percutaneous coronary intervention
,
replacement arthroplasty hip
,
intracranial sinus thrombosis
,
healthy volunteers/patients
,
hypertension
,
atrial fibrillation
,
thromboembolism
,
venous thromboembolism
,
essential hypertension
,
renal insufficiency
,
kidney diseases
,
thrombosis
,
stroke
,
cardiovascular diseases
,
isolated systolic hypertension
,
coronary artery disease
,
myocardial ischemia
,
diabetic nephropathies
,
coronary disease
,
arteriosclerosis
,
type 2 diabetes mellitus
,
diabetes mellitus
,
metabolic syndrome
,
heart valve diseases
,
replacement arthroplasty
,
cognitive dysfunction
,
atrial flutter
,
inflammation
,
syndrome
,
heart diseases
,
cerebral infarction
,
myocardial infarction
,
ischemia
,
infarction
,
dementia
,
cognition disorders
,
embolism
,
sepsis
,
neoplasms
,
transient ischemic attack
,
hemorrhage
,
liver cirrhosis
Sitravatinib
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
Ociperlimab
triple negative breast neoplasms
,
non-small-cell lung carcinoma
Cilmostim
glioblastoma
,
colorectal neoplasms
,
carcinoma
,
renal cell carcinoma
Gilvetmab
head and neck neoplasms
,
squamous cell carcinoma of head and neck
Surufatinib
neoplasms
,
neuroendocrine tumors
,
sarcoma
,
colorectal neoplasms
,
stomach neoplasms
,
small cell lung carcinoma
,
anaplastic thyroid carcinoma
,
lung neoplasms
,
lymphoma
,
osteosarcoma
,
ewing sarcoma
,
rhabdomyosarcoma
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
carcinosarcoma
,
mullerian mixed tumor
,
hematologic neoplasms
,
pancreatic neoplasms
Aglatimagene besadenovec
prostatic neoplasms
Vicriviroc
glioblastoma
,
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
carcinoma
,
colorectal neoplasms
,
lymphoma
,
hodgkin disease
,
infections
,
hiv
,
hiv infections
,
acquired immunodeficiency syndrome
,
immunologic deficiency syndromes
,
alzheimer disease
,
chronic hepatitis d
,
hepatitis b
,
chronic hepatitis b
,
hepatitis d
,
coinfection
,
hepatitis
,
hepatitis a
Tenofovir
insulin resistance
,
kidney diseases
,
chronic hepatitis d
,
hepatitis d
,
patient acceptance of health care
,
fatigue
,
relapsing-remitting multiple sclerosis
,
drug-related side effects and adverse reactions
,
progressive multifocal leukoencephalopathy
,
hepatitis b virus
,
pregnancy
,
chronic kidney failure
,
treatment adherence and compliance
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
breast feeding
,
hiv infections
,
hiv
,
hepatitis b
,
acquired immunodeficiency syndrome
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
chronic hepatitis
,
infections
,
coinfection
,
hiv-1
,
substance-related disorders
,
medication adherence
,
hepatitis c
,
tuberculosis
,
communicable diseases
,
healthy volunteers/patients
,
osteoporosis
,
chronic renal insufficiency
,
lipodystrophy
,
lymphoma
,
persistent infection
,
cognitive dysfunction
,
chronic hepatitis c
,
patient compliance
,
neoplasms
,
crush injuries
,
menopause
,
kidney transplantation
,
non-hodgkin lymphoma
,
burkitt lymphoma
,
viremia
,
herpes simplex
,
sleep wake disorders
,
anxiety disorders
,
opioid-related disorders
,
metabolic bone diseases
,
morphine dependence
,
renal insufficiency
,
kaposi sarcoma
,
harm reduction
,
recreational drug use
,
hiv-2
,
hiv seropositivity
,
aging
,
biliary liver cirrhosis
,
job syndrome
,
cardiovascular diseases
,
metabolic diseases
,
retinal diseases
,
metabolic syndrome
,
drug interactions
Doconexent
myositis
,
hypercholesterolemia
,
hyperlipidemias
,
metabolic diseases
,
congenital abnormalities
,
dyslipidemias
,
inborn genetic diseases
,
metabolic syndrome
,
metabolic brain diseases
,
newborn infant diseases
,
lipid metabolism disorders
,
inborn errors metabolism
,
hyperlipoproteinemias
,
inborn errors lipid metabolism
,
hypolipoproteinemias
,
hypobetalipoproteinemias
Regramostim
covid-19
,
pneumonia
,
inflammation
Lornoxicam
vitamin d deficiency
,
metabolic bone diseases
,
osteoporosis
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use